BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang Y, Fu S, Cao B, Hao K, Li Y, Huang J, Shi W, Duan C, Bai X, Tang K, Yang S, He X, Lu L. Prediction of overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt treatment: a cohort study. Hepatol Int 2021;15:730-40. [PMID: 33977364 DOI: 10.1007/s12072-021-10188-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen S, Wu Z, Shi F, Mai Q, Wang L, Wang F, Zhuang W, Chen X, Chen H, Xu B, Lai J, Guo W. Lenvatinib plus TACE with or without pembrolizumab for the treatment of initially unresectable hepatocellular carcinoma harbouring PD-L1 expression: a retrospective study. J Cancer Res Clin Oncol 2021. [PMID: 34453221 DOI: 10.1007/s00432-021-03767-4] [Reference Citation Analysis]
2 Li X, Partovi S, Coronado WM, Gadani S, Martin C, Thompson D, Levitin A, Kapoor B. Hepatic Encephalopathy After TIPS Placement: Predictive Factors, Prevention Strategies, and Management. Cardiovasc Intervent Radiol 2022. [PMID: 34981195 DOI: 10.1007/s00270-021-03045-3] [Reference Citation Analysis]